Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cestode mitochondrial oxidative phosphorylation machinery is a vital metabolic system responsible for ATP production in tapeworms, specifically adapted to the anaerobic or microaerophilic environments of the host's gastrointestinal tract (Tielens, A. G., 1994, Parasitology Today). This machinery differs significantly from mammalian systems by often utilizing a specialized NADH-fumarate reductase pathway, where fumarate acts as the terminal electron acceptor instead of oxygen to maintain redox balance (Kita, K., et al., 2002, Current Medicinal Chemistry). Key components of this system include Complex I (NADH dehydrogenase), Complex II (succinate dehydrogenase/fumarate reductase), and Complex V (ATP synthase). Anthelmintic drugs such as niclosamide target this machinery by uncoupling oxidative phosphorylation, which leads to a lethal depletion of ATP within the parasite (Weinbach, E. C., & Garbus, J., 1969, Nature). Because this metabolic pathway has distinct structural and functional differences from human mitochondrial respiration, it serves as a highly effective target for selective anthelmintic therapy against infections like taeniasis and echinococcosis (Walker, M., et al., 2004, Trends in Parasitology).
Uncoupling of oxidative phosphorylation and inhibition of anaerobic ATP production via the fumarate reductase pathway (PubChem CID 4477; WHO Model List of Essential Medicines).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cestode mitochondrial oxidative phosphorylation machinery (Cestode OXPHOS).